ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 112 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $10,716,000 | +53.2% | 1,777,037 | -8.5% | 0.22% | +63.5% |
Q3 2019 | $6,995,000 | +47.0% | 1,943,097 | +9.5% | 0.14% | +38.4% |
Q2 2019 | $4,757,000 | -13.1% | 1,775,127 | -4.0% | 0.10% | -14.7% |
Q1 2019 | $5,476,000 | -25.1% | 1,850,002 | -39.1% | 0.12% | +36.5% |
Q4 2018 | $7,310,000 | +67.4% | 3,037,004 | +155.9% | 0.08% | -10.5% |
Q3 2018 | $4,368,000 | +106.4% | 1,187,002 | +58.8% | 0.10% | +106.5% |
Q2 2018 | $2,116,000 | -31.5% | 747,600 | -10.1% | 0.05% | -35.2% |
Q1 2018 | $3,087,000 | +28.8% | 832,000 | 0.0% | 0.07% | +34.0% |
Q4 2017 | $2,396,000 | -36.7% | 832,000 | -1.4% | 0.05% | -31.2% |
Q3 2017 | $3,787,000 | -2.2% | 843,500 | 0.0% | 0.08% | -6.1% |
Q2 2017 | $3,872,000 | +9.0% | 843,500 | 0.0% | 0.08% | +13.9% |
Q1 2017 | $3,551,000 | +1.9% | 843,500 | 0.0% | 0.07% | -2.7% |
Q4 2016 | $3,484,000 | -35.9% | 843,500 | +25.8% | 0.07% | -33.9% |
Q3 2016 | $5,432,000 | +3.8% | 670,600 | 0.0% | 0.11% | -2.6% |
Q2 2016 | $5,231,000 | -4.8% | 670,600 | -5.7% | 0.12% | -4.2% |
Q1 2016 | $5,493,000 | -23.7% | 711,500 | +6.6% | 0.12% | -24.1% |
Q4 2015 | $7,201,000 | +51.0% | 667,400 | -3.3% | 0.16% | +43.6% |
Q3 2015 | $4,770,000 | -22.0% | 690,300 | 0.0% | 0.11% | -10.6% |
Q2 2015 | $6,116,000 | -15.1% | 690,300 | -5.6% | 0.12% | -10.9% |
Q1 2015 | $7,208,000 | -22.8% | 731,000 | -4.1% | 0.14% | -24.6% |
Q4 2014 | $9,339,000 | +65.6% | 762,400 | +35.0% | 0.18% | +60.5% |
Q3 2014 | $5,638,000 | – | 564,900 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IFP Advisors, Inc | 0 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |